Cargando…
Extracardiac (18)F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds
PURPOSE: (18)F-Florbetapir has been reported to show cardiac uptake in patients with systemic light-chain amyloidosis (AL). This study systematically assessed uptake of (18)F-florbetapir in patients with proven systemic amyloidosis at sites outside the heart. METHODS: Seventeen patients with proven...
Autores principales: | Wagner, T., Page, J., Burniston, M., Skillen, A., Ross, J. C., Manwani, R., McCool, D., Hawkins, P. N., Wechalekar, Ashutosh D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953997/ https://www.ncbi.nlm.nih.gov/pubmed/29651545 http://dx.doi.org/10.1007/s00259-018-3995-2 |
Ejemplares similares
-
Patient-specific optimisation of administered activity and acquisition times for (18)F-FDG PET imaging
por: Wickham, Fred, et al.
Publicado: (2017) -
Pilot Study of F18-Florbetapir in the Early Evaluation of Cardiac Amyloidosis
por: Sperry, Brett W., et al.
Publicado: (2021) -
The Evolving Epidemiology of Amyloidosis
por: Wechalekar, Ashutosh D.
Publicado: (2021) -
Radiation dosimetry of florbetapir F 18
por: Joshi, Abhinay D, et al.
Publicado: (2014) -
A Routine PET/CT Protocol with Streamlined Calculations for Assessing Cardiac Amyloidosis Using (18)F-Florbetapir
por: Osborne, Dustin R., et al.
Publicado: (2015)